Pulmonary manifestations and outcomes in paediatric ANCA–associated vasculitis: a single-centre experience. (23rd December 2020)

• Record Type: Journal Article
• Authors: Sayad, Edouard; Vogel, Tiphanie P; Guillerman, R Paul; Spielberg, David; McNeill, David Moreno; De Guzman, Marietta; Orman, Gunes; Silva-Carmona, Manuel
• Is Part Of: Rheumatology. Volume 60:Number 7(2021)
• Page Start: 3199
• Page End: 3208
• Publication Date: 2020-12-23
• Subjects: ANCA-associated vasculitis (AAV) -- paediatric vasculitis -- pulmonary haemorrhage -- paediatric AAV -- microscopic polyangiitis (MPA) -- granulomatosis with polyangiitis (GPA) -- chest CT; Rheumatism -- Periodicals; Rheumatology -- Periodicals; 616.723005
• DOI: 10.1093/rheumatology/keaa769
• Languages: English
• ISSNs: 1462-0324

Abstract

Abstract: Objectives: ANCA-associated vasculitis (AAV) usually involves the renal and respiratory systems, but the paediatric literature on pulmonary manifestations and outcomes is limited. We aimed to describe pulmonary manifestations and outcomes after therapy in a cohort of paediatric AAV (pAAV) patients. Methods: A retrospective chart review of all patients <19 years presenting to our institution with AAV between 1/2008 and 2/2018 was conducted. Patient demographics, clinical presentation, diagnostic testing, therapy and pulmonary outcomes over the first 3 years after presentation were evaluated. Results: A total of 38 patients were included; all had ANCA positivity by immunofluorescence. A total of 23 had microscopic polyangiitis (MPA), 13 had granulomatosis with polyangiitis and 2 had eosinophilic granulomatosis with polyangiitis. A total of 30 (79%) had pulmonary manifestations, with cough (73%) and pulmonary haemorrhage (67%) being the most common. Abnormalities were noted in 82% of chest CT scans reviewed, with nodules and ground-glass opacities being the most common. At 6, 12 and 36 months follow-up, respectively, 61.8%, 39.4% and 29% of patients continued to show pulmonary manifestations. Five MPA patients with re-haemorrhage are described in detail. Conclusion: MPA was more common than granulomatosis with polyangiitis, with pulmonary involvement being common in both. MPA patients had more severe pulmonary manifestations. Chest CT revealed abnormal findings in a majority of cases. A subgroup of young MPA patients experienced repeat pulmonary haemorrhage. Treatment modality and response were comparable in different subtypes of AAV, except for this young MPA group. Additional prospective studies are needed to better understand the different phenotypes of pAAV.